Michelle’s Immunotherapy Story: Finding Hope in Clinical Trials

Michelle’s Immunotherapy Story: Finding Hope in Clinical Trials

Since being diagnosed with melanoma in 2010, Michelle Boyer has participated in six different immunotherapy clinical trials, which she credits with prolonging her life. For more information on cancer immunotherapy, visit cancerresearch.org.

The trial she is on now, of the anti-PD-L1 drug atezolizumab (MPDL3280A) in combination with the targeted therapy cobimetinib, has caused her tumors to stop growing, and shrink in some cases. For Michelle and her family, participating in clinical research is about finding hope while seeking a cure.